hotspot -WSS

hotspot

author：comprehensive 2025-10-02 22:58:28 - browse：749

Slayman with (left to right) Dr. Leo Riella, Medical Director of Kidney Transplantation, Dr. Nahel Elias, Interim Chief, Division of Transplant Surgery, his partner, Faren, and Dr. Tatsuo Kawai, Director, Legorreta Center for Clinical Transplant Tolerance. -- HEALTH coverage from STAT — Rick Slayman, holding hands with his partner, Faren, poses with members of his Massachusetts General Hospital medical team before being going home last month. Michelle Rose/Massachusetts General Hospital

Rick Slayman, the first man to receive a kidney transplant from a genetically engineered pig, has died, according to a statement from his family and Massachusetts General Hospital, where he underwent the historic operation in March.

“Our family is deeply saddened about the sudden passing of our beloved Rick but take great comfort knowing he inspired so many,” his family said in the statement released Saturday evening.

The hospital did not say how or when Slayman died. A spokesperson declined to provide further information, citing “privacy issues.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： Why psychiatrists like me stop taking insurance

WSS

Pfizer highlights cancer drugs it thinks could reignite investor interest

ALS groups 'won't be played again' by the FDA, drug sponsors

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

Kenai launches with $82 million for Parkinson’s stem cell therapy

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Abortion pill mifepristone to soon be dispensed at CVS, Walgreens

explore

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

leisure time

Dobbs anniversary: the lost opportunity of abortion as health care

House looks to weaken Medicare negotiation

The high cost of giving birth even with insurance

How a scoliosis diagnosis changed the life of one young dancer

Novavax promises a turnaround & Lilly roils the obesity market

International team creates first chimeric human

The cancer drug shortage isn’t new — and neither are the solutions

RaDonda Vaught to speak at CommonSpirit event on patient safety

Alkermes shareholders re

3 trends to watch in health tech's hiring outlook for 2024

explore

Congress gives doctors Medicare pay bump

Why getting cancer drugs just got harder for rural patients

Antibiotic resistance and the global rise in human conflict

A Q&A with Aletha Maybank, AMA’s chief health equity officer

The FDA must approve intranasal treatments for anaphylaxis

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

knowledge

hotspot

knowledge

focus